Coya Therapeutics, Inc. (COYA)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$47.3M
Stockholders' Equity
$43.3M
Cash & Equivalents
$43.2M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Coya Therapeutics, Inc. reported revenue of $243,745, net income of -$6.6M, and total assets of $47.3M. Every figure below is taken directly from Coya Therapeutics, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2022–FY2025 · as reported

$7.9M-$6.6M-$21.2M
FY2022FY2023FY2024FY2025
Revenue$7.9MNet income-$21.2M
FY2022 revenue
$0
FY2025 revenue
$7.9M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$7.9M-$21.2M
FY2024$3.6M-$14.9M
FY2023$6.0M-$8.0M
FY2022$0-$12.2M
FY2021—-$4.9M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 14, 2026on EDGAR ↗
8-KOct 5, 2026on EDGAR ↗
8-KSep 15, 2026on EDGAR ↗
8-KAug 11, 2026on EDGAR ↗
10-QAug 11, 2026on EDGAR ↗
8-KJun 25, 2026on EDGAR ↗
DEF 14AMay 13, 2026on EDGAR ↗
8-KMay 12, 2026on EDGAR ↗
8-KMay 12, 2026on EDGAR ↗
10-QMay 12, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$47.3Msource ↗
Stockholders’ Equity$43.3Msource ↗
Cash & Equivalents$43.2Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$243,745source ↗
Net Income-$6.6Msource ↗
Operating Income-$7.0Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$5.0Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.28source ↗
EPS (basic)$-0.28source ↗
Shares Outstanding23.5Msource ↗
Cash from Operations-$7.4Msource ↗
Cash from Financing-$166,069source ↗
Cash from Investing-$1,656source ↗

Restatement history

Point-in-time

No material restatements detected across 112 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches COYA’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/COYA

MCP tool: get_sec_fundamentals ticker=COYA

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/COYA/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=COYA as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/COYA/history

MCP tool: get_fundamentals_history ticker=COYA

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/COYA

MCP tool: get_financial_health ticker=COYA

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.